13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 39 holding rows worth $750,316,000.
- Accession
- 0001140361-17-042799
- Filer
- CIK 1587114
- Filed
- 2017-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2017
A holdings report, 40 entries on the cover page, a total value of $750,316,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $750,316,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,943,164 | $102,775,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 1,735,677 | $93,379,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 5,459,583 | $86,098,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,107,600 | $76,401,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,766,852 | $56,314,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 2,860,019 | $39,983,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 689,986 | $29,566,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 240,776 | $24,499,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 3,622,271 | $21,263,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 3,934,849 | $19,871,000 | thousands by filing date | |
| TOCAGEN INC | 888846102 | COM | 1,502,373 | $18,720,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,250,000 | $15,375,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 829,771 | $15,077,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 908,525 | $14,482,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 1,500,000 | $13,425,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 405,400 | $12,653,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 564,248 | $12,272,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B606 | COM NEW | 3,000,000 | $12,270,000 | thousands by filing date | |
| VERTEX PHARMACEUTICALS INC | 92532F900 | CALL | 67,600 | $10,278,000 | thousands by filing date | call |
| IRONWOOD PHARMACEUTICALS INC | 46333X908 | COM CL A | 620,000 | $9,777,000 | thousands by filing date | call |
| OMEROS CORP | 682143102 | COM | 450,000 | $9,729,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,262,678 | $8,960,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 5,239,225 | $6,549,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 957,992 | $5,508,000 | thousands by filing date | |
| OVASCIENCE INC | 69014Q101 | COM | 3,512,332 | $4,988,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 159,535 | $4,307,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 544,880 | $4,277,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 222,388 | $3,336,000 | thousands by filing date | |
| CLEMENTIA PHARMACEUTICALS IN | 185575107 | COM | 194,166 | $3,279,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 762,947 | $2,785,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 25,765 | $2,123,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 90,114 | $2,065,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 30,000 | $1,632,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 60,000 | $1,549,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 104,000 | $1,531,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 17,060 | $1,087,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 9,800 | $1,009,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 45,000 | $855,000 | thousands by filing date | |
| SPRING BK PHARMACEUTICALS IN | 849431101 | COM | 16,000 | $269,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-17-042799 | this filing | 2017-11-14 | acceptance time not in the bulk data set |